Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Patterns of resource utilization and cost for postmenopausal women with hormone-receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer in Europe

Fig. 5

Cohort A: hormone therapy versus chemotherapy regimens for (a) monitoring tests and (b) healthcare resource utilization. Cohort A received HT 1st line followed by chemotherapy 2nd line and any treatment 3rd line. Abbreviations: CT, computed tomography; GP, general practitioner; HT, hormone therapy; MRI, magnetic resonance imaging; PET, positron emission tomography; TT, targeted therapy

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us